Genetics, Technology Promising For MS
Finding the genetic source of the disease will help determine the most effective treatments.
Read MorePosted by Clinical Lab Products | Nov 5, 2006 | Miscellaneous |
Finding the genetic source of the disease will help determine the most effective treatments.
Read MorePosted by Clinical Lab Products | Oct 26, 2006 | Cancer, Miscellaneous |
Gentris Corporation announced today that it has completed an FDA 510(k) submission and is planning to market six Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6).
Read MorePosted by Clinical Lab Products | Oct 10, 2006 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
Digene President Resigns Charles M. Fleischman, Digene Corp’s president, COO, and CFO, is resigning from those positions as well as from the company’s board of directors. His resignation as CFO was effective October 1, when he
Read MorePosted by Clinical Lab Products | Sep 14, 2006 | Miscellaneous |
Companies Adeza Biomedical Corp Antek HealthWare LLC Audit MicroControls, Inc bioMérieux Ciphergen Biosystems Inc David G. Rhoads Associates Inc Genzyme Diagnostics Millipore Nanogen, Inc
Read MorePosted by Clinical Lab Products | Sep 14, 2006 | Cancer, Library Preparation Systems, Mass Spectrometry Reagents & Test Kits, Miscellaneous |
Researchers have devised a new method to detect a spectrum of known gene mutations in a variety of cancer genes that they say is both sensitive and cost-efficient.
Read More